Department of General Surgery, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Animal Center, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Int J Cancer. 2017 Nov 15;141(10):1942-1949. doi: 10.1002/ijc.30827. Epub 2017 Jun 24.
A meta-analysis was conducted to determine the influence of gender on overall survival (OS) and cancer-specific survival (CSS) in colorectal cancer patients. Major databases were searched for clinical trials, which compare survival differences between male and female for colorectal cancer patients. A list of these studies and references, published in English and Chinese from 1960 to 2017, was obtained independently by two reviewers from databases such as PubMed, Medline, ScienceDirect, the China National Knowledge Infrastructure (CNKI) and Web of Science. Overall survival and cancer-specific survival were compared using Review Manager 5.3. Females had significantly better OS (hazard ratio [HR] = 0.87; 95% confidence interval [CI] = 0.85-0.89) and CSS (HR = 0.92; 95% CI = 0.89-0.95) than males after meta-analysis. These results suggest that gender seems to be a significant factor influencing survival results among colorectal cancer patients.
进行了一项荟萃分析,以确定性别对结直肠癌患者总生存期(OS)和癌症特异性生存期(CSS)的影响。主要数据库中搜索了临床试验,这些试验比较了男性和女性结直肠癌患者的生存差异。通过两位审稿人从 PubMed、Medline、ScienceDirect、中国国家知识基础设施(CNKI)和 Web of Science 等数据库中独立获取了这些研究的列表及其参考文献,这些研究和参考文献均以英文和中文发表,时间范围为 1960 年至 2017 年。使用 Review Manager 5.3 比较了总生存期和癌症特异性生存期。荟萃分析后,女性的 OS(风险比 [HR] = 0.87;95%置信区间 [CI] = 0.85-0.89)和 CSS(HR = 0.92;95%CI = 0.89-0.95)均显著优于男性。这些结果表明,性别似乎是影响结直肠癌患者生存结果的一个重要因素。